Contract facts
UnrestrictedDEVELOPMENT OF EPETRABOROLE AS A NOVEL THERAPEUTIC FOR MELIOIDOSIS AND ADDITIONAL ANTIMICROBIAL RESISTANT (AMR) BACTERIAL BIOTHREAT PATHOGENS. is a federal Unrestricted award for National Institutes Of Health Niaid held by An2 Therapeutics, Inc. Estimated value $17.8M ($9.2M obligated). Current period of performance ends Jul 31, 2027. Last award drew 30 bidders. Place of performance: MENLO PARK CA. Related solicitation PHS-2021-1.
DEVELOPMENT OF EPETRABOROLE AS A NOVEL THERAPEUTIC FOR MELIOIDOSIS AND ADDITIONAL ANTIMICROBIAL RESISTANT (AMR) BACTERIAL BIOTHREAT PATHOGENS.
Recompete timing
PublicCurrent PoP ends Jul 31, 2027 (307 days remaining). Agencies typically plan 12–18 months ahead — at 10.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N93022C00059? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordAn2 Therapeutics, Inc — $4.3M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93022C00059?
75N93022C00059 (AMR development epetraborole NOVEL therapeutic) is a National Institutes Of Health Niaid award with a potential value of $17.8M, currently held by An2 Therapeutics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93022C00059?
National Institutes Of Health Niaid awarded 75N93022C00059 to An2 Therapeutics, Inc (potential $17.8M).
Who is the incumbent on 75N93022C00059?
An2 Therapeutics, Inc is the incumbent with $4.3M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Jul 31, 2027.
When does An2 Therapeutics, Inc’s 75N93022C00059 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N93022C00059? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.